BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Prognosis
14 results:

  • 1. Successful immunotherapy with PD-1 Iinhibitor for advanced pancreatic cancer: report of two cases and review of literature.
    Qiu L; Liu C; Li H
    Anticancer Drugs; 2024 Mar; 35(3):263-270. PubMed ID: 38194502
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
    Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
    Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
    Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
    Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multiomics Analysis.
    Bao X; Li Q; Chen J; Chen D; Ye C; Dai X; Wang Y; Li X; Rong X; Cheng F; Jiang M; Zhu Z; Ding Y; Sun R; Liu C; Huang L; Jin Y; Li B; Lu J; Wu W; Guo Y; Fu W; Langley SR; Tano V; Fang W; Guo T; Sheng J; Zhao P; Ruan J
    Cancer Immunol Res; 2022 Jul; 10(7):811-828. PubMed ID: 35604302
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts.
    Li Z; Jia Y; Zhu H; Yuan H; Xing X; Xin Y; Ma T; Pang F; Zhang Y; Hu Y; Jia S; Ji J
    Int J Cancer; 2022 Oct; 151(8):1382-1393. PubMed ID: 35567574
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Treatment landscape of metastatic pancreatic cancer.
    De Dosso S; Siebenhüner AR; Winder T; Meisel A; Fritsch R; Astaras C; Szturz P; Borner M
    Cancer Treat Rev; 2021 May; 96():102180. PubMed ID: 33812339
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
    Ma H; Song B; Guo S; Li G; Jin G
    Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of pancreatic cancer Patients Receiving Neoadjuvant Treatment.
    Yoon KA; Woo SM; Kim YH; Kong SY; Lee MK; Han SS; Kim TH; Lee WJ; Park SJ
    Gut Liver; 2019 Nov; 13(6):683-689. PubMed ID: 30970447
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.
    Koutsioumpa M; Hatziapostolou M; Polytarchou C; Tolosa EJ; Almada LL; Mahurkar-Joshi S; Williams J; Tirado-Rodriguez AB; Huerta-Yepez S; Karavias D; Kourea H; Poultsides GA; Struhl K; Dawson DW; Donahue TR; Fernández-Zapico ME; Iliopoulos D
    Gut; 2019 Jul; 68(7):1271-1286. PubMed ID: 30337373
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Use of Biomarkers in Early Diagnostics of pancreatic cancer.
    Kunovsky L; Tesarikova P; Kala Z; Kroupa R; Kysela P; Dolina J; Trna J
    Can J Gastroenterol Hepatol; 2018; 2018():5389820. PubMed ID: 30186820
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Reduced Expression of Histone Methyltransferases KMT2C and kmt2d Correlates with Improved Outcome in pancreatic Ductal Adenocarcinoma.
    Dawkins JB; Wang J; Maniati E; Heward JA; Koniali L; Kocher HM; Martin SA; Chelala C; Balkwill FR; Fitzgibbon J; Grose RP
    Cancer Res; 2016 Aug; 76(16):4861-71. PubMed ID: 27280393
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature.
    Ghatnekar O; Andersson R; Svensson M; Persson U; Ringdahl U; Zeilon P; Borrebaeck CA
    Int J Cancer; 2013 Nov; 133(10):2392-7. PubMed ID: 23649606
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [prognosis in pancreatic carcinoma].
    Friess H; Isenmann R; Berberat P; Kleeff J; Büchler MW
    Ther Umsch; 1996 May; 53(5):401-7. PubMed ID: 8685859
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Tumor of the pancreas. Support treatment].
    Da Silva Mde L
    Arq Gastroenterol; 1994; 31(3):111-8. PubMed ID: 7538290
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.